chartexchange

DNLI
Denali Therapeutics Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
18.41USD+2.278%(+0.41)2,368,841
Pre-marketNov 18, 2026 9:27:30 AM EST
18.00USD0.000%(0.00)
After-hoursNov 18, 2026 4:26:30 PM EST
18.40USD-0.054%(-0.01)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Ryan Watts
HQ
South San Francisco, CA, USA
Previous Close
$18.00
Beta
1.52
52-Week High
$27.30 2026-07-09
52-Week Low
$15.34 2026-01-05
SMA 50
$19.55
SMA 200
$21.17
Avg. Vol 10D
1.38M
Avg. Vol 30D
1.67M
Avg. Vol 90D
1.58M
Relative Vol
1.42
160.29M
150.13M
14,694,882
0.4100%
1,200,000
1,413
DNLI Profile

denali therapeutics inc. ("denali") is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including alzheimer's disease, parkinson's disease, als and others. denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. founding investors include fidelity biosciences, arch venture partners, flagship ventures and the alaska permanent fund (represented by crestline investors).

DNLI Performance
PeriodPriceDateChangeBeta
1W18.892026-11-12-2.54%2.689
1M18.042026-10-19+2.05%1.501
3M25.692026-08-19-28.34%1.498
6M18.112026-05-19+1.66%0.971
1Y16.922025-11-19+8.81%1.522
2Y24.342024-11-19-24.36%—
5Y47.112021-11-19-60.92%1.559
DNLI Stock Summary

Denali Therapeutics Inc. Common Stock (NASDAQ:DNLI) stock price today is $18.41, and today's volume is 2,368,841. DNLI is up 2.278% today. The 30 day average volume is 1.67M. DNLI market cap is $2.95B with 160.29M shares outstanding.